| Fludarabine studied in …STUDIED_INderived200 of 1,319show all (up to 200) |
|---|
| → studied in | NCT02498912Phase 1 · active not recruiting Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid Tumors · 1,319 trials list this drug (392 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06865664Phase 1 · recruiting FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma · 1,319 trials list this drug (392 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06904066Phase 1 · recruiting Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies · 1,319 trials list this drug (392 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07509034Phase 1 · recruiting Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease · 1,319 trials list this drug (392 active) | — | — | Solid Neoplasm,Extrapulmonary Neuroendocrine Carcinoma,Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07524530Phase 2 · not yet recruiting Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers · 1,319 trials list this drug (392 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07572136Phase 1 · recruiting Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL) · 1,319 trials list this drug (392 active) | — | — | Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07672483Phase 1 · not yet recruiting IL-12 Genetically Engineered Myeloid Cells in Participants With Relapsed, Refractory Solid Tumors · 1,319 trials list this drug (392 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07770802Phase 1 · recruiting Clinical Study of HS-IT101 Injection in the Treatment of Advanced Renal Cancer · 1,319 trials list this drug (392 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07830342Phase 1 · recruiting A Clinical Study of HS-IT101 Injection in Patients With Advanced Non-Small Cell Lung Cancer · 1,319 trials list this drug (392 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03412877Phase 2 · recruiting Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer · 1,319 trials list this drug (392 active) | — | — | Endocrine Neoplasm,Malignant Breast Neoplasm,Multiple Myeloma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03494569Phase 1 · suspended Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome · 1,319 trials list this drug (392 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Secondary Acute Myeloid Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07174427Phase 3 · recruiting Multi-center Study of TBI-1301 (INN: Mipetresgene Autoleucel; Mip-cel) in Patients With NY-ESO-1 Positive Synovial Sarcoma · 1,319 trials list this drug (392 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03779854Phase 2 · active not recruiting Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant · 1,319 trials list this drug (392 active) | — | — | Acute Leukemia,Acute Lymphoblastic Leukemia,Burkitt Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04923893Phase 3 · active not recruiting A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy · 1,319 trials list this drug (392 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04989803Phase 1/Phase 2 · recruiting Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma · 1,319 trials list this drug (392 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05564390Phase 2 · recruiting MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial) · 1,319 trials list this drug (392 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic/Myeloproliferative Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05922930Phase 1/Phase 2 · active not recruiting Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer · 1,319 trials list this drug (392 active) | — | — | Adenocarcinoma,Malignant Pancreatic Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06577025Phase 2 · active not recruiting A Study of Different Sequences of Cilta-cel, Talquetamab in Combination With Daratumumab and Teclistamab in Combination With Daratumumab Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in Participants With Standard-risk Newly Diagnosed Multiple Myeloma · 1,319 trials list this drug (392 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07149857Phase 2 · recruiting A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel · 1,319 trials list this drug (392 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07838714Phase 1 · recruiting Dual-Targeted Umbilical Cord Blood CAR-T Cells Against CD19 and CD22 for the Treatment of Relapsed or Refractory Acute B-Cell Lymphoblastic Leukemia · 1,319 trials list this drug (392 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04083495Phase 2 · recruiting CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma · 1,319 trials list this drug (392 active) | — | — | Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06871410Phase 1 · recruiting Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia · 1,319 trials list this drug (392 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04732845Phase 1 · active not recruiting Human AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid Malignancies · 1,319 trials list this drug (392 active) | — | — | Acute Lymphoblastic Leukemia,Non-Hodgkin Lymphoma,Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06253520Phase 1 · active not recruiting Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer · 1,319 trials list this drug (392 active) | — | — | Malignant Breast Neoplasm,Malignant Digestive System Neoplasm,Malignant Genitourinary System Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07015242Phase 2 · recruiting A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma · 1,319 trials list this drug (392 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01174121Phase 2 · recruiting Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer · 1,319 trials list this drug (392 active) | — | — | Breast Carcinoma,Malignant Pancreatic Neoplasm,Malignant Ovarian Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03182244Phase 3 · completed A Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase 3 (FLT3) Mutation · 1,319 trials list this drug (392 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05359211Phase 1 · completed NKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell Lymphoma · 1,319 trials list this drug (392 active) | — | — | Diffuse Large B-Cell Lymphoma,Primary Mediastinal Large B-Cell Lymphoma,Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07162038Phase 1 · recruiting Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation · 1,319 trials list this drug (392 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00801489Phase 2 · recruiting Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome · 1,319 trials list this drug (392 active) | — | — | De Novo Myelodysplastic Syndrome,Myelodysplastic Syndrome with Excess Blasts,Adult Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03214562Phase 1/Phase 2 · recruiting Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia · 1,319 trials list this drug (392 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05327023Phase 1/Phase 2 · recruiting Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies · 1,319 trials list this drug (392 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04375631Phase 1 · recruiting CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia · 1,319 trials list this drug (392 active) | — | — | Myelodysplastic Syndrome,Acute Leukemia of Ambiguous Lineage,Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05955261Phase 2 · recruiting A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia · 1,319 trials list this drug (392 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07223021Phase 3 · recruiting A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia · 1,319 trials list this drug (392 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07297667Phase 1 · recruiting GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours · 1,319 trials list this drug (392 active) | — | — | Alveolar Soft Part Sarcoma,Renal Cell Carcinoma,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02629809Phase 2 · active not recruiting Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic Leukemia · 1,319 trials list this drug (392 active) | — | — | Chronic Lymphocytic Leukemia,Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05681780Phase 1 · recruiting Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC · 1,319 trials list this drug (392 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06096038Phase 1 · recruiting Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC · 1,319 trials list this drug (392 active) | — | — | Malignant Neoplasm,Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03849651Phase 2 · active not recruiting TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies · 1,319 trials list this drug (392 active) | — | — | Acute Lymphoblastic Leukemia,Hodgkin Lymphoma,Juvenile Myelomonocytic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05554939Phase 1/Phase 2 · recruiting Allogenic CD19-targeting CAR-γδT Cell Therapy in R/R NHL · 1,319 trials list this drug (392 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06236425Phase 1 · completed TBio-4101 and Pembro wi/ or w/o Chemo in Recurrent/Metastatic HNSCC · 1,319 trials list this drug (392 active) | — | — | Squamous Cell Carcinoma,Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06615479Phase 3 · recruiting A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2) · 1,319 trials list this drug (392 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06968195Phase 1 · suspended Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma · 1,319 trials list this drug (392 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07819396Phase 2 · not yet recruiting Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome · 1,319 trials list this drug (392 active) | — | — | Acute Leukemia,Acute Lymphoblastic Leukemia,Burkitt Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04579523Phase 1 · withdrawn ²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor Stem Cell Transplant for the Treatment of Newly Diagnosed, Recurrent, or Refractory High-Risk Multiple Myeloma · 1,319 trials list this drug (392 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05436418Phase 1/Phase 2 · recruiting The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation · 1,319 trials list this drug (392 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05470283Phase 1 · active not recruiting Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma · 1,319 trials list this drug (392 active) | — | — | Neoplasm,Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07087002Phase 1 · recruiting GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults · 1,319 trials list this drug (392 active) | — | — | Central Nervous System Embryonal Tumor,Embryonal Tumor with Multilayered Rosettes,Medulloblastoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07328503Phase 2 · recruiting CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia · 1,319 trials list this drug (392 active) | — | — | Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06480565Phase 1/Phase 2 · active not recruiting A Phase 1/2 Trial of ADI-270 in ccRCC · 1,319 trials list this drug (392 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06680661Phase 2 · suspended ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis · 1,319 trials list this drug (392 active) | — | — | Lymphoma,Acute Lymphoblastic Leukemia,Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07793435Phase 1/Phase 2 · not yet recruiting A Phase 1/2 Trial of ADI-212 in mCRPC · 1,319 trials list this drug (392 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06383572Phase 1/Phase 2 · recruiting Phase I/II Study of Engineered T Cell Receptor-Modified NK Cells Targeting PRAME in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Myeloid Malignancies · 1,319 trials list this drug (392 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06954987Phase 2 · not yet recruiting Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial) · 1,319 trials list this drug (392 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03666000Phase 1 · recruiting Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL) · 1,319 trials list this drug (392 active) | — | — | Non-Hodgkin Lymphoma,B Acute Lymphoblastic Leukemia,Chronic Lymphocytic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07444632Phase 1 · recruiting Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies · 1,319 trials list this drug (392 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01949129Phase 2/Phase 3 · recruiting Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia · 1,319 trials list this drug (392 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05849662Phase 1/Phase 2 · recruiting A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia · 1,319 trials list this drug (392 active) | — | — | Juvenile Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06043323Phase 2 · recruiting A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma · 1,319 trials list this drug (392 active) | — | — | Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06930651Phase 1/Phase 2 · recruiting A Phase I/II Study of CAR.70-Engineered IL15-Transduced Cord Blood-Derived NK Cells With TGF-beta Receptor 2 (TGFBR2) Knock Out in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Myeloid Malignancies · 1,319 trials list this drug (392 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07479797Phase 3 · recruiting Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy · 1,319 trials list this drug (392 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07613723Phase 1 · recruiting A Study to Test the Safety, Tolerability and Effect of ZI-MA4-1 for Patients With Locally Advanced or Metastatic Solid Malignancies · 1,319 trials list this drug (392 active) | — | — | Malignant Head and Neck Neoplasm,Lung Non-Small Cell Carcinoma,Malignant Ovarian Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07803653Phase 1 · not yet recruiting IL-18 Armored STEAP1 CAR T Cells for the Treatment of Metastatic Castration Resistant Prostate Cancer · 1,319 trials list this drug (392 active) | — | — | Malignant Prostate Neoplasm,Castration-Resistant Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07358260Phase 1 · recruiting B7-H3.CD28Z.CART in Solid Tumors · 1,319 trials list this drug (392 active) | — | — | Childhood Solid Neoplasm,Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07390539Phase 1 · recruiting B7-H3.CD28Z.CART in CNS Neoplasms · 1,319 trials list this drug (392 active) | — | — | Central Nervous System Neoplasm,Atypical Teratoid/Rhabdoid Tumor,Embryonal Tumor with Multilayered Rosettes+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05707273Phase 1 · active not recruiting CD19-Car T Cell Therapy for the Treatment of Older Adults With Acute Lymphoblastic Leukemia in First Remission · 1,319 trials list this drug (392 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05993299Phase 2 · completed Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Untreated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell Liposarcoma · 1,319 trials list this drug (392 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07025824Phase 2 · recruiting Evaluation of Treosulfan Versus Melphalan Conditioning Followed by PTCy in Patients With AML and MDS Undergoing Allogeneic Transplantation · 1,319 trials list this drug (392 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04262843Phase 2 · active not recruiting Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute Leukemia · 1,319 trials list this drug (392 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07227571Phase 1 · recruiting Genetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Refractory or Recurrent/Progressive Osteosarcoma, FIERCe Trial · 1,319 trials list this drug (392 active) | — | — | Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07428993Phase 2 · recruiting Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma · 1,319 trials list this drug (392 active) | — | — | Childhood Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02133196Phase 2 · recruiting T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer · 1,319 trials list this drug (392 active) | — | — | Adenocarcinoma,Squamous Cell Carcinoma,Adenosquamous Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04881240Phase 1 · recruiting Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia · 1,319 trials list this drug (392 active) | — | — | Acute Lymphoblastic Leukemia,Childhood Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06500273Phase 2 · recruiting Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL · 1,319 trials list this drug (392 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02048813Phase 3 · active not recruiting Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · 1,319 trials list this drug (392 active) | — | — | Chronic Lymphocytic Leukemia,Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07257419Phase 1 · recruiting CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma · 1,319 trials list this drug (392 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Childhood Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04696731Phase 1 · active not recruiting Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma · 1,319 trials list this drug (392 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02159495Phase 1 · active not recruiting Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm · 1,319 trials list this drug (392 active) | — | — | Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia,Adult Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06834282Phase 1 · recruiting CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF) · 1,319 trials list this drug (392 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06885697Phase 1 · recruiting Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma · 1,319 trials list this drug (392 active) | — | — | Neoplasm,Gastric Neoplasm,Lung Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06940297Phase 2 · recruiting Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma · 1,319 trials list this drug (392 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07166419Phase 1 · active not recruiting Anti-CD19/20/22 Chimeric Antigen Receptor T Cells (TriCAR19.20.22 T Cells) for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, and Chronic Lymphocytic Leukemia · 1,319 trials list this drug (392 active) | — | — | Acute Lymphoblastic Leukemia,Lymphoblastic Lymphoma,Non-Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05761171Phase 2 · active not recruiting A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia · 1,319 trials list this drug (392 active) | — | — | Acute Lymphoblastic Leukemia,Acute Leukemia of Ambiguous Lineage,Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05826535Phase 1/Phase 2 · recruiting Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma · 1,319 trials list this drug (392 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06079164Phase 1 · active not recruiting Study of KITE-197 in Participants With Relapsed or Refractory Large B-cell Lymphoma · 1,319 trials list this drug (392 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06247787Phase 1 · recruiting A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy · 1,319 trials list this drug (392 active) | — | — | Childhood Myelodysplastic Syndrome,Juvenile Myelomonocytic Leukemia,Childhood Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03190941Phase 1/Phase 2 · recruiting Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients · 1,319 trials list this drug (392 active) | — | — | Malignant Digestive System Neoplasm,Malignant Gastric Neoplasm,Malignant Pancreatic Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05183035Phase 3 · recruiting Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML) · 1,319 trials list this drug (392 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06158828Phase 1/Phase 2 · recruiting Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML · 1,319 trials list this drug (392 active) | — | — | Acute Myeloid Leukemia,Childhood Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07055477Phase 1 · recruiting A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL) · 1,319 trials list this drug (392 active) | — | — | Anaplastic Large Cell Lymphoma,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,Hepatosplenic T-Cell Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07059975early Phase 1 · recruiting UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML · 1,319 trials list this drug (392 active) | — | — | Acute Myeloid Leukemia,Childhood Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02621021Phase 2 · recruiting A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab · 1,319 trials list this drug (392 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04007029Phase 1 · active not recruiting Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic Leukemia · 1,319 trials list this drug (392 active) | — | — | Chronic Lymphocytic Leukemia,Small Lymphocytic Lymphoma,Diffuse Large B-Cell Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05110742Phase 1/Phase 2 · recruiting Phase I/II Study of CD5 CAR Engineered IL15-Transduced Cord Blood-Derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Hematological Malignances · 1,319 trials list this drug (392 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06001788Phase 1 · recruiting Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia · 1,319 trials list this drug (392 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Leukemia,Acute Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06066359Phase 1/Phase 2 · recruiting Ph I/II Trial of Cord Blood-derived NK Cells With NY-ESO-1 TCR/IL-15 for R/R Myeloma · 1,319 trials list this drug (392 active) | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07101432Phase 1 · recruiting Phase I Study of Preconditioning Radiation Therapy With IL-15 Transduced TGFBR2 KO CAR.TROP2-engineered Cord Blood-derived NK Cells in Patients With Advanced Head and Neck Cancer (RADIANCE-NK) · 1,319 trials list this drug (392 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07137481Phase 2 · not yet recruiting Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Aggressive T Cell Hematological Malignancies · 1,319 trials list this drug (392 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07582172Phase 2 · recruiting Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome · 1,319 trials list this drug (392 active) | — | — | Myelodysplastic Syndrome,Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01810588Phase 2 · completed Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation · 1,319 trials list this drug (392 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07228624Phase 2 · recruiting Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes · 1,319 trials list this drug (392 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm,Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07604233Phase 1/Phase 2 · not yet recruiting Phase 1/2 FLAG-IDA, VEN and Asciminib in CML and Ph+ AML · 1,319 trials list this drug (392 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04880434Phase 2 · completed Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 3) · 1,319 trials list this drug (392 active) | — | — | Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07565220Phase 1 · recruiting Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies · 1,319 trials list this drug (392 active) | — | — | Acute Leukemia,Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05225363Phase 1 · recruiting Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer · 1,319 trials list this drug (392 active) | — | — | Platinum-Resistant Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06001385Phase 2 · active not recruiting HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis · 1,319 trials list this drug (392 active) | — | — | Lymphoma,Acute Leukemia,Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07304154Phase 1 · recruiting A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases · 1,319 trials list this drug (392 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07764978Phase 3 · recruiting Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT · 1,319 trials list this drug (392 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02830724Phase 1/Phase 2 · recruiting Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers · 1,319 trials list this drug (392 active) | — | — | Malignant Breast Neoplasm,Melanoma,Malignant Pancreatic Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06186401Phase 1 · recruiting Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells · 1,319 trials list this drug (392 active) | — | — | Glioblastoma,MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06703346Phase 2 · completed Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Treated Advanced (Metastatic or Unresectable) Synovial Sarcoma or Myxoid/Round Cell Liposarcoma · 1,319 trials list this drug (392 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00338377Phase 2 · active not recruiting Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma · 1,319 trials list this drug (392 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04608487Phase 1 · active not recruiting Axi-cel in CNS Lymphoma · 1,319 trials list this drug (392 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05495464early Phase 1 · active not recruiting A Pilot "Window-3" Study of Acalabrutinib Plus Rituximab Followed by Brexucabtagene Autoleucel Therapy in Patients With Previously Untreated High-risk Mantle Cell Lymphoma · 1,319 trials list this drug (392 active) | — | — | Lymphoma,Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07759102Phase 1 · not yet recruiting Allogeneic ORCA-Q Stem Cell Transplant for the Treatment of Relapsed and Refractory High Risk Multiple Myeloma · 1,319 trials list this drug (392 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03573700Phase 1/Phase 2 · active not recruiting Evaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia · 1,319 trials list this drug (392 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03967223Phase 2 · active not recruiting Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors · 1,319 trials list this drug (392 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04708054Phase 2/Phase 3 · recruiting Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS · 1,319 trials list this drug (392 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06236139Phase 1/Phase 2 · recruiting Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer · 1,319 trials list this drug (392 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07758673Phase 1 · not yet recruiting Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic Lymphoma · 1,319 trials list this drug (392 active) | — | — | B Acute Lymphoblastic Leukemia,B Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06237881Phase 1/Phase 2 · active not recruiting A Phase 1/2 Study of KSQ-001EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 Gene, in Patients With Select Advanced Solid Tumors · 1,319 trials list this drug (392 active) | — | — | Head and Neck Neoplasm,Solid Neoplasm,Lung Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05020444Phase 1 · active not recruiting TriPRIL CAR T Cells in Multiple Myeloma · 1,319 trials list this drug (392 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05092451Phase 1/Phase 2 · recruiting Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances · 1,319 trials list this drug (392 active) | — | — | Germ Cell Tumor,B-Cell Malignant Neoplasm,Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06486051Phase 2 · recruiting A Study of Atlacabtagene Autoleucel CAR T-cells for Adults With Relapsed Large B-cell Lymphoma · 1,319 trials list this drug (392 active) | — | — | Transformed Non-Hodgkin Lymphoma,Diffuse Large B-Cell Lymphoma,Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02861417Phase 2 · active not recruiting Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant · 1,319 trials list this drug (392 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Acute Lymphoblastic Leukemia,Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04994808Phase 2 · terminated Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia · 1,319 trials list this drug (392 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06609928Phase 1 · recruiting FH-FOLR1 Chimeric Antigen Receptor T Cell Therapy for Treating Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia · 1,319 trials list this drug (392 active) | — | — | Childhood Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04539366Phase 1 · suspended Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, GD2-CAR PERSIST Trial · 1,319 trials list this drug (392 active) | — | — | Osteosarcoma,Childhood Osteosarcoma,Neuroblastoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06358430Phase 1 · active not recruiting Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With Minimal Residual Disease (MRD) · 1,319 trials list this drug (392 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06220201Phase 1 · active not recruiting A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2) · 1,319 trials list this drug (392 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03696784Phase 1 · active not recruiting Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma · 1,319 trials list this drug (392 active) | — | — | B-Cell Malignant Neoplasm,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05703854Phase 1/Phase 2 · suspended Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Advanced Renal Cell Carcinoma, Mesothelioma and Osteosarcoma · 1,319 trials list this drug (392 active) | — | — | Malignant Mesothelioma,Osteosarcoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06287944Phase 1 · recruiting 225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome · 1,319 trials list this drug (392 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02727803Phase 2 · recruiting Personalized NK Cell Therapy in CBT · 1,319 trials list this drug (392 active) | — | — | Acute Lymphoblastic Leukemia,Hodgkin Lymphoma,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05442515Phase 1/Phase 2 · recruiting CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies · 1,319 trials list this drug (392 active) | — | — | B-Cell Malignant Neoplasm,Leukemia,Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05457556Phase 3 · active not recruiting Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome · 1,319 trials list this drug (392 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07735637Phase 3 · not yet recruiting A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6). · 1,319 trials list this drug (392 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07737769Phase 1 · not yet recruiting Arsenic Trioxide to Prevent Relapse in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome · 1,319 trials list this drug (392 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06034470Phase 1 · active not recruiting Combination Chemotherapy (FLAG-Ida) With Pivekimab Sunirine (PVEK) for the Treatment of Newly Diagnosed Adverse Risk Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms · 1,319 trials list this drug (392 active) | — | — | Myelodysplastic Syndrome,Myelodysplastic/Myeloproliferative Neoplasm,Myeloproliferative Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06083883Phase 1 · recruiting Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1 · 1,319 trials list this drug (392 active) | — | — | Myxoid Liposarcoma,Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06413498Phase 3 · active not recruiting A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma · 1,319 trials list this drug (392 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07509008Phase 1/Phase 2 · not yet recruiting Phase 1/2 Window Of Opportunity Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum · 1,319 trials list this drug (392 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07564232Phase 1 · recruiting Phase 1 Study Of LNK001 In Advanced Or Metastatic Clear Cell Renal Cell Carcinoma · 1,319 trials list this drug (392 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06319456Phase 3 · recruiting A Study of Lisaftoclax (APG-2575) Combined With Acalabrutinib Versus Immunochemotherapy for Newly Diagnosed CLL/SLL. · 1,319 trials list this drug (392 active) | — | — | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06347068Phase 1 · recruiting Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells · 1,319 trials list this drug (392 active) | — | — | Malignant Breast Neoplasm,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07411599Phase 1/Phase 2 · recruiting Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial") · 1,319 trials list this drug (392 active) | — | — | Carcinomatosis,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03531736Phase 1 · active not recruiting T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Conditioned With a Reduced Intensity Regimen in Patients With Hematologic Malignancies and Aplastic Anemia · 1,319 trials list this drug (392 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06699771Phase 1 · recruiting Phase 1 to Investigate the Safety, Tolerability, and Efficacy of GCC2005 in Patients With R/R NK and T-cell Malignancies · 1,319 trials list this drug (392 active) | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07614048available Intermediate-size IND for Treatment of Patients With Advanced Cancer Using T Cells Engineered to Express TCR Targeting Mutant KRAS · 1,319 trials list this drug (392 active) | — | — | Colorectal Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04877613Phase 1 · active not recruiting GFRα4 CAR T Cells in MTC Patients · 1,319 trials list this drug (392 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06013423Phase 2 · recruiting Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases · 1,319 trials list this drug (392 active) | — | — | Hematopoietic and Lymphatic System Neoplasm,Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07686107Phase 2 · not yet recruiting Trial of Revumenib Plus FLA Chemotherapy for Children With Relapsed or Refractory NUP98-rearranged AML." · 1,319 trials list this drug (392 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07720180Phase 2 · not yet recruiting Study of Autologous, Metabolically Optimized, CD137+ Tumor-Infiltrating Lymphocytes Followed by Consolidative Oral Cyclophosphamide, Bevacizumab, and Pembrolizumab · 1,319 trials list this drug (392 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02251548Phase 2 · active not recruiting A Phase II Study of Ibrutinib Plus FCR in Previously Untreated, Younger Patients With Chronic Lymphocytic Leukemia · 1,319 trials list this drug (392 active) | — | — | Leukemia,Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07046078Phase 2 · recruiting Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer · 1,319 trials list this drug (392 active) | — | — | Myelodysplastic Syndrome,Acute Leukemia of Ambiguous Lineage,Acute Myeloid Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03480360Phase 3 · completed Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression · 1,319 trials list this drug (392 active) | — | — | Lymphoma,Myelodysplastic Syndrome,Myeloproliferative Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05052528Phase 1 · recruiting Fludarabine and Cyclophosphamide With or Without Rituximab Before CD19 Chimeric Antigen Receptor T Cells for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma · 1,319 trials list this drug (392 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05334329Phase 1 · active not recruiting Genetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint Inhibitors · 1,319 trials list this drug (392 active) | — | — | Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04022239Phase 1/Phase 2 · recruiting Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant · 1,319 trials list this drug (392 active) | — | — | Hematopoietic and Lymphatic System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05797233Phase 1 · active not recruiting Trial of Anti-CD19 and Anti-CD20 Bicistronic Chimeric Antigen Receptor T Cells for Treating B-Cell Malignancies · 1,319 trials list this drug (392 active) | — | — | B-Cell Malignant Neoplasm,Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06364423Phase 1/Phase 2 · recruiting Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias · 1,319 trials list this drug (392 active) | — | — | Leukemia,Acute Lymphoblastic Leukemia,Lymphoblastic Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07164469Phase 2 · not yet recruiting Phase 2 Trial of CD70.CAR NK Cells for Patients With Primary Refractory or Early Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma · 1,319 trials list this drug (392 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05400122Phase 1 · suspended Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer · 1,319 trials list this drug (392 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Acute Lymphoblastic Leukemia,Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04792489Phase 2 · recruiting DALY II USA/ MB-CART2019.1 for DLBCL · 1,319 trials list this drug (392 active) | — | — | Central Nervous System Lymphoma,Transformed Non-Hodgkin Lymphoma,Diffuse Large B-Cell Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05451849Phase 1/Phase 2 · terminated A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer · 1,319 trials list this drug (392 active) | — | — | Malignant Mesothelioma,Malignant Pancreatic Neoplasm,Ovarian Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05478837Phase 1 · terminated Genetically Modified Cells (KIND T Cells) for the Treatment of HLA-A*0201-Positive Patients With H3.3K27M-Mutated Glioma · 1,319 trials list this drug (392 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07228273Phase 2 · recruiting Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid Leukemia · 1,319 trials list this drug (392 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03399773Phase 2 · active not recruiting Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes · 1,319 trials list this drug (392 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05077527Phase 1 · recruiting Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma · 1,319 trials list this drug (392 active) | — | — | Non-Hodgkin Lymphoma,AIDS-Related Non-Hodgkin Lymphoma,Transformed B-Cell Non-Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05665062Phase 1 · active not recruiting Autologous CD19 CAR-T Cell Therapy (SYNCAR-001) + Orthogonal IL-2 (STK-009) in Subjects With CD19+ Hematologic Malignancies · 1,319 trials list this drug (392 active) | — | — | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,Non-Hodgkin Lymphoma,Diffuse Large B-Cell Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03591510Phase 2 · active not recruiting A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML · 1,319 trials list this drug (392 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06464965Phase 1 · completed Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic Cancer · 1,319 trials list this drug (392 active) | — | — | Malignant Gastric Neoplasm,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05634785Phase 2 · completed CD30 CAR for CD30+ NSGCT · 1,319 trials list this drug (392 active) | — | — | Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05139004Phase 1 · active not recruiting 90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome · 1,319 trials list this drug (392 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Secondary Acute Myeloid Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05805605Phase 2 · recruiting Allo HSCT Using RIC and PTCy for Hematological Diseases · 1,319 trials list this drug (392 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06043713Phase 1 · recruiting Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V Mutations · 1,319 trials list this drug (392 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04809766Phase 1 · terminated Mesothelin-Specific T-Cells (FH-TCR-Tᴍsʟɴ) for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma · 1,319 trials list this drug (392 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03710421Phase 1 · suspended CS1-CAR T Therapy Following Chemotherapy in Treating Patients With Relapsed or Refractory CS1 Positive Multiple Myeloma · 1,319 trials list this drug (392 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04836507Phase 1/Phase 2 · recruiting Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia Patients · 1,319 trials list this drug (392 active) | — | — | Acute Lymphoblastic Leukemia,Diffuse Large B-Cell Lymphoma,Primary Mediastinal Large B-Cell Lymphoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06996119Phase 1 · recruiting Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant · 1,319 trials list this drug (392 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03241940Phase 1 · active not recruiting Study of CD19/CD22 Chimeric Antigen Receptor T Cells in Children & Young Adults w/ Recurrent or Refractory B Cell Malignancies · 1,319 trials list this drug (392 active) | — | — | Acute Lymphoblastic Leukemia,Adult Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04098393Phase 1 · active not recruiting Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation · 1,319 trials list this drug (392 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05653271Phase 1 · completed ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies · 1,319 trials list this drug (392 active) | — | — | B-Cell Malignant Neoplasm,Non-Hodgkin Lymphoma,Burkitt Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07676877Phase 1 · not yet recruiting Lymphodepletion With Low Dose Total Body Irradiation Before Standard of Care Tisagenlecleucel for the Treatment of Relapsed and Recurrent Large B-cell Lymphoma · 1,319 trials list this drug (392 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02724163Phase 3 · active not recruiting International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia · 1,319 trials list this drug (392 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06815003Phase 2 · recruiting Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning · 1,319 trials list this drug (392 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Myeloproliferative Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06802315Phase 2 · recruiting Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS) · 1,319 trials list this drug (392 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06961357Phase 1/Phase 2 · recruiting Clinical Trial of CD40L-augmented TIL for Patients With Advanced Melanoma · 1,319 trials list this drug (392 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05672459Phase 1/Phase 2 · active not recruiting A Safety And Efficacy Study Of HLA-G- Targeted CAR-T Cells IVS-3001 In Subjects With Previously Treated Advanced HLA-G-Positive Solid Tumors · 1,319 trials list this drug (392 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06253663Phase 2 · active not recruiting Study of KTE-X19 in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma or Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia · 1,319 trials list this drug (392 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02577094Phase 1/Phase 2 · withdrawn Testing a Reduced Conditioning Regimen FB2A2 Preceded by a Fractionated Radio-immunotherapy (RIT) With 90Y-Epratuzumab Before Allogeneic Stem Cell Transplantation for Patients With Lymphocyte B CD22 Positive Acute Lymphoblastic Leukemia · 1,319 trials list this drug (392 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03128034Phase 1/Phase 2 · recruiting 211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia · 1,319 trials list this drug (392 active) | — | — | Acute Lymphoblastic Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03277729Phase 1/Phase 2 · active not recruiting A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas · 1,319 trials list this drug (392 active) | — | — | B-Cell Non-Hodgkin Lymphoma,Central Nervous System Lymphoma,Chronic Lymphocytic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03670966Phase 1/Phase 2 · recruiting 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome · 1,319 trials list this drug (392 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Acute Lymphoblastic Leukemia,Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04545762Phase 1 · recruiting Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma · 1,319 trials list this drug (392 active) | — | — | Non-Hodgkin Lymphoma,Small Lymphocytic Lymphoma,Transformed Non-Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04024761Phase 1 · recruiting A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation · 1,319 trials list this drug (392 active) | — | — | Juvenile Myelomonocytic Leukemia,Myelodysplastic Syndrome,Myeloproliferative Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04083183Phase 1/Phase 2 · recruiting Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases · 1,319 trials list this drug (392 active) | — | — | Non-Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07074496early Phase 1 · recruiting Efficacy, Safety, and Pharmacokinetics of ThisCART19A Combined With Olverembatinib in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. · 1,319 trials list this drug (392 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03602612Phase 1 · completed T Cells Expressing a Novel Fully-Human Anti-BCMA CAR for Treating Multiple Myeloma · 1,319 trials list this drug (392 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |